September 25, 2026
Botox and filler consent in Finland — a prescription for toxin, no rules for fillers, and what the form must show
Finland treats botulinum toxin as a prescription medicine but sets no qualification or age limit for fillers. Where the law asks little, the consent form carries more.
Printable template (PDF)
A health questionnaire and consent for an injectable treatment, with aftercare advice — the same document clinics have clients sign on a tablet in Aprovo. Add your clinic's details and print.
A consent form for botulinum toxin or filler carries more weight than most paperwork in a clinic. The treatment changes a face for months, the result settles only after days or weeks, and complications — from a drooping eyelid to a blocked blood vessel — are rare but real.
Who may inject
Botulinum toxin is a medicine that may be given only on a licensed doctor's prescription. According to guidance published by the Finnish Medicines Agency Fimea in July 2026, a doctor must be immediately reachable to come to the premises while it is given, and a nurse may inject it only with appropriate training and the doctor's written authorisation.
Fillers carry no professional requirement. They are medical devices, not medicines — since June 2023 fillers without a medical purpose fall under the EU Medical Device Regulation (Annex XVI) — and cosmetic products may not be used for injections at all. A service offered outside health care is covered by the Act on the Safety of Consumer Services (185/2025). A reform modelled on Sweden's has been discussed for years but is not in force.
Age
No statutory age limit applies to either treatment. For a minor, their maturity and a guardian's consent decide; many practitioners do not inject for cosmetic reasons below 18. That is a clinic policy, and the form should say so.
What the form should show
Identity and age, with the ID produced.
Contraindications. Pregnancy and breastfeeding, neuromuscular conditions such as myasthenia gravis, skin infection at the site, previous permanent fillers, bleeding disorders and anticoagulants, known allergies.
The product. Name, batch number and quantity — units of toxin, millilitres of filler — and the injection sites on a face map.
Risks named. For toxin: asymmetry, eyelid or brow droop, headache, spread. For fillers: bruising, swelling, lumps, infection and the rare but serious vascular occlusion, which can cause tissue death or, very rarely, sight loss.
Expectations. Toxin reaches full effect after days and wears off over months; filler settles over weeks.
Before photos and aftercare, acknowledged. And three separate consents: to treatment, to health data processing, to marketing use of photos. For toxin, a note of the prescribing doctor's availability — the one point where Finnish law imposes a condition worth evidencing.
The short version
Finland asks less of a filler practitioner than any neighbouring market, which makes the consent form the main evidence of what was done and what was explained. Record the product, batch, sites, risks and expectations, and keep them with the before photos. The supervisory authority for the data is the Office of the Data Protection Ombudsman.
This article is for information only and is not legal advice.
Read next
Protect your business today
Try Aprovo free for 30 days and leave the paperwork behind.
Start your free trial


